{"transactions":[{"id":4618377,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-09-15T21:03:43.000Z","date":"2026-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1936,"price":156.22,"value":302441.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of PRSUs. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"21,985 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":24025,"source":{"system":"sec-edgar","filing":"0001776977-26-000013","document":"wk-form4_1789506221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776977/000177697726000013/wk-form4_1789506221.xml","form_type":"4"}},{"id":4618376,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-09-15T21:03:43.000Z","date":"2026-09-11","kind":"grant","planned":false,"acquired":true,"shares":3587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person was previously granted performance restricted stock units (PRSUs) that vest upon the achievement of certain performance metrics, the achievement of one of which was certified on September 11, 2026."}],"balance_after":25961,"source":{"system":"sec-edgar","filing":"0001776977-26-000013","document":"wk-form4_1789506221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776977/000177697726000013/wk-form4_1789506221.xml","form_type":"4"}},{"id":750181,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2026-06-04T22:02:44.000Z","date":"2026-06-02","kind":"exercise","planned":true,"acquired":false,"shares":24965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option was granted February 5, 2018 and vested in 48 equal monthly installments beginning March 5, 2018."}],"balance_after":0,"derivative":{"exercise_price":81.49,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":24965},"source":{"system":"sec-edgar","filing":"0001776977-26-000010","document":"wk-form4_1780610561.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000010/wk-form4_1780610561.xml","form_type":"4"}},{"id":750180,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-06-04T22:02:44.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":3520,"price":158.5897,"value":558235.744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.  Additionally,\nIssuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $158.26 to $158.91.  The Reporting Person has provided to the issuer, and\nwill provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"20,334 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":22374,"source":{"system":"sec-edgar","filing":"0001776977-26-000010","document":"wk-form4_1780610561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000010/wk-form4_1780610561.xml","form_type":"4"}},{"id":750179,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-06-04T22:02:44.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":9521,"price":157.6161,"value":1500662.8881,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.  Additionally,\nIssuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $157.26 to $158.25.  The Reporting Person has provided to the issuer, and\nwill provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":25894,"source":{"system":"sec-edgar","filing":"0001776977-26-000010","document":"wk-form4_1780610561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000010/wk-form4_1780610561.xml","form_type":"4"}},{"id":750178,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-06-04T22:02:44.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":4216,"price":156.766,"value":660925.456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.  Additionally,\nIssuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $156.26 to $157.25.  The Reporting Person has provided to the issuer, and\nwill provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":35415,"source":{"system":"sec-edgar","filing":"0001776977-26-000010","document":"wk-form4_1780610561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000010/wk-form4_1780610561.xml","form_type":"4"}},{"id":750177,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-06-04T22:02:44.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":5466,"price":155.4566,"value":849725.7756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.  Additionally,\nIssuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $155.20 to $156.19.  The Reporting Person has provided to the issuer, and\nwill provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":39631,"source":{"system":"sec-edgar","filing":"0001776977-26-000010","document":"wk-form4_1780610561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000010/wk-form4_1780610561.xml","form_type":"4"}},{"id":750176,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-06-04T22:02:44.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":14214,"price":154.8252,"value":2200685.3928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.  Additionally,\nIssuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $154.20 to $155.19.  The Reporting Person has provided to the issuer, and\nwill provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":45097,"source":{"system":"sec-edgar","filing":"0001776977-26-000010","document":"wk-form4_1780610561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000010/wk-form4_1780610561.xml","form_type":"4"}},{"id":750175,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-06-04T22:02:44.000Z","date":"2026-06-02","kind":"exercise","planned":true,"acquired":true,"shares":24965,"price":81.49,"value":2034397.85,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 176 shares purchased on February 27, 2026 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan."}],"balance_after":59311,"source":{"system":"sec-edgar","filing":"0001776977-26-000010","document":"wk-form4_1780610561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000010/wk-form4_1780610561.xml","form_type":"4"}},{"id":902291,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":4754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2027, February 13, 2028, February 13, 2029, and February 13, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2027, February 13, 2028, February 13, 2029, and February 13, 2030."}],"balance_after":4754,"derivative":{"underlying":"Common Stock","underlying_shares":4754},"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902290,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Stock Option","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":27100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2026 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":27100,"derivative":{"exercise_price":124.12,"expiration_date":"2036-02-13","underlying":"Common Stock","underlying_shares":27100},"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902289,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":false,"shares":1510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This RSU was granted to the Reporting Person on February 13, 2023.  In accordance with the terms of the RSU, the award vested as to 1,509 shares on February 13, 2024, vested as to 1,509 shares on February 13, 2025, vested as to 1,510 shares on February 13, 2026, and will vest as to 1,510 shares on February 13, 2027, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"This RSU was granted to the Reporting Person on February 13, 2023.  In accordance with the terms of the RSU, the award vested as to 1,509 shares on February 13, 2024, vested as to 1,509 shares on February 13, 2025, vested as to 1,510 shares on February 13, 2026, and will vest as to 1,510 shares on February 13, 2027, subject to the terms and conditions of the award."}],"balance_after":1510,"derivative":{"underlying":"Common Stock","underlying_shares":1510},"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902288,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":false,"shares":1401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This RSU was granted to the Reporting Person on February 13, 2024.  In accordance with the terms of the RSU, the award vested as to 1,401 shares on February 13, 2025, vested as to 1,401 shares on February 13, 2026, and will vest as to 1,401 shares on February 13, 2027, and 1,401 shares on February 13, 2028, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This RSU was granted to the Reporting Person on February 13, 2024.  In accordance with the terms of the RSU, the award vested as to 1,401 shares on February 13, 2025, vested as to 1,401 shares on February 13, 2026, and will vest as to 1,401 shares on February 13, 2027, and 1,401 shares on February 13, 2028, subject to the terms and conditions of the award."}],"balance_after":2802,"derivative":{"underlying":"Common Stock","underlying_shares":1401},"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902287,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":false,"shares":1387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This RSU was granted to the Reporting Person on February 12, 2025. In accordance with the terms of the RSU, the award vested as to 1,387 shares on February 12, 2026, and will vest as to 1,387 shares on February 12, 2027, 1,387 shares on February 12, 2028, and 1,387 shares on February 12, 2029, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This RSU was granted to the Reporting Person on February 12, 2025. In accordance with the terms of the RSU, the award vested as to 1,387 shares on February 12, 2026, and will vest as to 1,387 shares on February 12, 2027, 1,387 shares on February 12, 2028, and 1,387 shares on February 12, 2029, subject to the terms and conditions of the award."}],"balance_after":4161,"derivative":{"underlying":"Common Stock","underlying_shares":1387},"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902286,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":5378,"price":124.12,"value":667517.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of restricted stock units (\"RSUs\") or performance restricted stock units (\"PRSUs\"), as applicable. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"32,306 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":34170,"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902285,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":9968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On May 19, 2023, the Reporting Person was granted PRSUs representing the right to receive shares of the Issuer's common stock based upon the achievement of specified performance metrics over the three-year performance period ending on December 31, 2025. Effective February 13, 2026, the achievement of the applicable performance metrics and the resulting payout level were certified, and, as a result of such certification, the PRSUs vested at 125% of the target number of shares subject to the award."}],"balance_after":39548,"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902284,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":815,"price":124.12,"value":101157.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of restricted stock units (\"RSUs\") or performance restricted stock units (\"PRSUs\"), as applicable. No shares were sold."}],"balance_after":29580,"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902283,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":1510,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30395,"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902282,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":756,"price":124.12,"value":93834.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of restricted stock units (\"RSUs\") or performance restricted stock units (\"PRSUs\"), as applicable. No shares were sold."}],"balance_after":28885,"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902281,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":1401,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29641,"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902280,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":749,"price":123.1,"value":92201.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of restricted stock units (\"RSUs\") or performance restricted stock units (\"PRSUs\"), as applicable. No shares were sold."}],"balance_after":28240,"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":902279,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:46:18.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":true,"shares":1387,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28989,"source":{"system":"sec-edgar","filing":"0001776977-26-000007","document":"wk-form4_1771368375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000007/wk-form4_1771368375.xml","form_type":"4"}},{"id":922923,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-03T23:05:24.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":1741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU was granted to the Reporting Person on January 31, 2022. In accordance with the terms of the RSU, the award vested as to 1,740 shares on January 31, 2023, vested as to 1,740 shares on January 31, 2024, vested as to 1,740 shares on January 31, 2025, and vested as to 1,741 shares on January 31, 2026, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This RSU was granted to the Reporting Person on January 31, 2022. In accordance with the terms of the RSU, the award vested as to 1,740 shares on January 31, 2023, vested as to 1,740 shares on January 31, 2024, vested as to 1,740 shares on January 31, 2025, and vested as to 1,741 shares on January 31, 2026, subject to the terms and conditions of the award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1741},"source":{"system":"sec-edgar","filing":"0001776977-26-000005","document":"wk-form4_1770159920.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000005/wk-form4_1770159920.xml","form_type":"4"}},{"id":922922,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-03T23:05:24.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":997,"price":136.06,"value":135651.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of restricted stock units (\"RSUs\"). No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"25,738 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":27602,"source":{"system":"sec-edgar","filing":"0001776977-26-000005","document":"wk-form4_1770159920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000005/wk-form4_1770159920.xml","form_type":"4"}},{"id":922921,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-03T23:05:24.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":1741,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28599,"source":{"system":"sec-edgar","filing":"0001776977-26-000005","document":"wk-form4_1770159920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000177697726000005/wk-form4_1770159920.xml","form_type":"4"}},{"id":1141111,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Incentive Stock Option","published_at":"2025-05-20T20:43:39.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":false,"shares":6468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents option of which 1/4th of the shares underlying the option became vested and exercisable on November October 2, 2018 and an additional 1/48th of the shares underlying the option became vested and excercisable each month thereafter.  These options were set to expire ten years from the date of grant on October 2, 2027."}],"balance_after":0,"derivative":{"exercise_price":61.82,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":6468},"source":{"system":"sec-edgar","filing":"0000914475-25-000106","document":"wk-form4_1747773812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000106/wk-form4_1747773812.xml","form_type":"4"}},{"id":1141110,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-05-20T20:43:39.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":true,"shares":6468,"price":61.82,"value":399851.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"24,994 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes an aggregate of 200 shares purchased on February 28, 2025 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan."}],"balance_after":26858,"source":{"system":"sec-edgar","filing":"0000914475-25-000106","document":"wk-form4_1747773812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000106/wk-form4_1747773812.xml","form_type":"4"}},{"id":1268353,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-15T00:13:07.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":false,"shares":1401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This RSU was granted to the Reporting Person on February 13, 2024.  In accordance with the terms of the RSU, the award vested as to 1,401 shares on February 13, 2025, and will vest as to 1,401 shares on February 13, 2026, 1,401 shares on February 13, 2027, and 1,401 shares on February 13, 2028, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"This RSU was granted to the Reporting Person on February 13, 2024.  In accordance with the terms of the RSU, the award vested as to 1,401 shares on February 13, 2025, and will vest as to 1,401 shares on February 13, 2026, 1,401 shares on February 13, 2027, and 1,401 shares on February 13, 2028, subject to the terms and conditions of the award."}],"balance_after":4203,"derivative":{"underlying":"Common Stock","underlying_shares":1401},"source":{"system":"sec-edgar","filing":"0000914475-25-000075","document":"wk-form4_1739578380.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000075/wk-form4_1739578380.xml","form_type":"4"}},{"id":1268352,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-15T00:13:07.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":false,"shares":1509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This RSU was granted to the Reporting Person on February 13, 2023.  In accordance with the terms of the RSU, the award vested as to 1,509 shares on February 13, 2024, vested as to 1,509 shares on February 13, 2025, and will vest as to 1,510 shares on February 13, 2026, and to 1,510 shares on February 13, 2027, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"This RSU was granted to the Reporting Person on February 13, 2023.  In accordance with the terms of the RSU, the award vested as to 1,509 shares on February 13, 2024, vested as to 1,509 shares on February 13, 2025, and will vest as to 1,510 shares on February 13, 2026, and to 1,510 shares on February 13, 2027, subject to the terms and conditions of the award."}],"balance_after":3020,"derivative":{"underlying":"Common Stock","underlying_shares":1509},"source":{"system":"sec-edgar","filing":"0000914475-25-000075","document":"wk-form4_1739578380.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000075/wk-form4_1739578380.xml","form_type":"4"}},{"id":1268351,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-15T00:13:07.000Z","date":"2025-02-12","kind":"grant","planned":true,"acquired":true,"shares":5548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 12, 2026, February 12, 2027, February 12, 2028, and February 12, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 12, 2026, February 12, 2027, February 12, 2028, and February 12, 2029."}],"balance_after":5548,"derivative":{"underlying":"Common Stock","underlying_shares":5548},"source":{"system":"sec-edgar","filing":"0000914475-25-000075","document":"wk-form4_1739578380.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000075/wk-form4_1739578380.xml","form_type":"4"}},{"id":1268350,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Stock Option","published_at":"2025-02-15T00:13:07.000Z","date":"2025-02-12","kind":"grant","planned":true,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 12, 2025 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":29600,"derivative":{"exercise_price":117.18,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000914475-25-000075","document":"wk-form4_1739578380.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000075/wk-form4_1739578380.xml","form_type":"4"}},{"id":1268349,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-02-15T00:13:07.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":755,"price":116.7988,"value":88183.094,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $115.98 to $117.78. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"18,526 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":20190,"source":{"system":"sec-edgar","filing":"0000914475-25-000075","document":"wk-form4_1739578380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000075/wk-form4_1739578380.xml","form_type":"4"}},{"id":1268348,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-02-15T00:13:07.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":true,"shares":1401,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20945,"source":{"system":"sec-edgar","filing":"0000914475-25-000075","document":"wk-form4_1739578380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000075/wk-form4_1739578380.xml","form_type":"4"}},{"id":1268347,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-02-15T00:13:07.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":796,"price":116.7664,"value":92946.0544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $115.98 to $117.76. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":19544,"source":{"system":"sec-edgar","filing":"0000914475-25-000075","document":"wk-form4_1739578380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000075/wk-form4_1739578380.xml","form_type":"4"}},{"id":1268346,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-02-15T00:13:07.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":true,"shares":1509,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20340,"source":{"system":"sec-edgar","filing":"0000914475-25-000075","document":"wk-form4_1739578380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000075/wk-form4_1739578380.xml","form_type":"4"}},{"id":1272440,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-13T00:00:19.000Z","date":"2025-02-08","kind":"exercise","planned":true,"acquired":false,"shares":1329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This RSU was granted to the Reporting Person on February 8, 2021.  In accordance with the terms of the RSU, the award vested as to 1,328 shares on February 8, 2022, vested as to 1,328 shares on February 8, 2023, vested as to 1,329 shares on February 8, 2024, and vested as to 1,329 shares on February 8, 2025, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This RSU was granted to the Reporting Person on February 8, 2021.  In accordance with the terms of the RSU, the award vested as to 1,328 shares on February 8, 2022, vested as to 1,328 shares on February 8, 2023, vested as to 1,329 shares on February 8, 2024, and vested as to 1,329 shares on February 8, 2025, subject to the terms and conditions of the award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1329},"source":{"system":"sec-edgar","filing":"0000914475-25-000053","document":"wk-form4_1739404812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000053/wk-form4_1739404812.xml","form_type":"4"}},{"id":1272439,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-02-13T00:00:19.000Z","date":"2025-02-10","kind":"sale","planned":true,"acquired":false,"shares":700,"price":118.275,"value":82792.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2021. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $116.13 to $123.57. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"16,538 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":18831,"source":{"system":"sec-edgar","filing":"0000914475-25-000053","document":"wk-form4_1739404812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000053/wk-form4_1739404812.xml","form_type":"4"}},{"id":1272438,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-02-13T00:00:19.000Z","date":"2025-02-08","kind":"exercise","planned":true,"acquired":true,"shares":1329,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19531,"source":{"system":"sec-edgar","filing":"0000914475-25-000053","document":"wk-form4_1739404812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000053/wk-form4_1739404812.xml","form_type":"4"}},{"id":1286002,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-04T23:05:29.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":false,"shares":1740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This RSU was granted to the Reporting Person on January 31, 2022. In accordance with the terms of the RSU, the award vested as to 1,740 shares on January 31, 2023, vested as to 1,740 shares on January 31, 2024, vested as to 1,740 shares on January 31, 2025, and will vest as to 1,741 shares on January 31, 2026, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This RSU was granted to the Reporting Person on January 31, 2022. In accordance with the terms of the RSU, the award vested as to 1,740 shares on January 31, 2023, vested as to 1,740 shares on January 31, 2024, vested as to 1,740 shares on January 31, 2025, and will vest as to 1,741 shares on January 31, 2026, subject to the terms and conditions of the award."}],"balance_after":1741,"derivative":{"underlying":"Common Stock","underlying_shares":1740},"source":{"system":"sec-edgar","filing":"0000914475-25-000032","document":"wk-form4_1738710322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000032/wk-form4_1738710322.xml","form_type":"4"}},{"id":1286001,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:05:29.000Z","date":"2025-01-31","kind":"sale","planned":true,"acquired":false,"shares":824,"price":152.8879,"value":125979.6296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.85 to $153.62. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"16,538 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power"}],"balance_after":18202,"source":{"system":"sec-edgar","filing":"0000914475-25-000032","document":"wk-form4_1738710322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000032/wk-form4_1738710322.xml","form_type":"4"}},{"id":1286000,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:05:29.000Z","date":"2025-01-31","kind":"sale","planned":true,"acquired":false,"shares":916,"price":152.8879,"value":140045.3164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 1, 2022. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.85 to $153.62. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":19026,"source":{"system":"sec-edgar","filing":"0000914475-25-000032","document":"wk-form4_1738710322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000032/wk-form4_1738710322.xml","form_type":"4"}},{"id":1285999,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:05:29.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":true,"shares":1740,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19942,"source":{"system":"sec-edgar","filing":"0000914475-25-000032","document":"wk-form4_1738710322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000032/wk-form4_1738710322.xml","form_type":"4"}},{"id":1441473,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-08-05T21:40:36.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":12632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents option of which 1/4th of the shares underlying the option becomes vested and exercisable on October 2, 2018 and an additional 1/48th of the shares underlying the option becomes vested and excercisable each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":61.82,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":12632},"source":{"system":"sec-edgar","filing":"0000914475-24-000187","document":"wk-form4_1722894030.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000187/wk-form4_1722894030.xml","form_type":"4"}},{"id":1441472,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-08-05T21:40:36.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":12632,"price":153.2629,"value":1936016.9528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.53 to $156.51. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"16,538 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":18202,"source":{"system":"sec-edgar","filing":"0000914475-24-000187","document":"wk-form4_1722894030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000187/wk-form4_1722894030.xml","form_type":"4"}},{"id":1441471,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-08-05T21:40:36.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":12632,"price":61.82,"value":780910.24,"ownership":{"direct":true},"balance_after":30834,"source":{"system":"sec-edgar","filing":"0000914475-24-000187","document":"wk-form4_1722894030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000187/wk-form4_1722894030.xml","form_type":"4"}},{"id":1452090,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-07-18T21:12:15.000Z","date":"2024-07-16","kind":"exercise","planned":true,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents option of which 1/4th of the shares underlying the option becomes vested and exercisable on October 2, 2018 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":12632,"derivative":{"exercise_price":61.82,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0000914475-24-000176","document":"wk-form4_1721337128.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000176/wk-form4_1721337128.xml","form_type":"4"}},{"id":1452089,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-07-18T21:12:15.000Z","date":"2024-07-16","kind":"sale","planned":true,"acquired":false,"shares":900,"price":150.04,"value":135036.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.18. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"16,538 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power"}],"balance_after":18202,"source":{"system":"sec-edgar","filing":"0000914475-24-000176","document":"wk-form4_1721337128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000176/wk-form4_1721337128.xml","form_type":"4"}},{"id":1452088,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-07-18T21:12:15.000Z","date":"2024-07-16","kind":"exercise","planned":true,"acquired":true,"shares":900,"price":61.82,"value":55638.0,"ownership":{"direct":true},"balance_after":19102,"source":{"system":"sec-edgar","filing":"0000914475-24-000176","document":"wk-form4_1721337128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000176/wk-form4_1721337128.xml","form_type":"4"}},{"id":1464243,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-07-03T01:36:32.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents option of which 1/4th of the shares underlying the option became vested and exercisable on October 2, 2018 and an additional 1/48th of the shares underlying the option became vested and excercisable each month thereafter.   These options will expire ten years from the date of grant on October 2, 2027."}],"balance_after":13532,"derivative":{"exercise_price":61.82,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000914475-24-000166","document":"wk-form4_1719970585.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000166/wk-form4_1719970585.xml","form_type":"4"}},{"id":1464242,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-07-03T01:36:32.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":140.1864,"value":1401864.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.48. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"16,538 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":18202,"source":{"system":"sec-edgar","filing":"0000914475-24-000166","document":"wk-form4_1719970585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000166/wk-form4_1719970585.xml","form_type":"4"}},{"id":1464241,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-07-03T01:36:32.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":61.82,"value":618200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 226 shares purchased on  February 29, 2024 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan."}],"balance_after":28202,"source":{"system":"sec-edgar","filing":"0000914475-24-000166","document":"wk-form4_1719970585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000166/wk-form4_1719970585.xml","form_type":"4"}},{"id":1641720,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-15T22:35:44.000Z","date":"2024-02-13","kind":"grant","planned":true,"acquired":true,"shares":5604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2025, February 13, 2026, February 13, 2027, and February 13, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2025, February 13, 2026, February 13, 2027, and February 13, 2028."}],"balance_after":5604,"derivative":{"underlying":"Common Stock","underlying_shares":5604},"source":{"system":"sec-edgar","filing":"0000914475-24-000070","document":"wk-form4_1708036535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000070/wk-form4_1708036535.xml","form_type":"4"}},{"id":1641719,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Stock Option","published_at":"2024-02-15T22:35:44.000Z","date":"2024-02-13","kind":"grant","planned":true,"acquired":true,"shares":28161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2024 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":28161,"derivative":{"exercise_price":133.84,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":28161},"source":{"system":"sec-edgar","filing":"0000914475-24-000070","document":"wk-form4_1708036535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000070/wk-form4_1708036535.xml","form_type":"4"}},{"id":1641718,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-02-15T22:35:44.000Z","date":"2024-02-13","kind":"sale","planned":true,"acquired":false,"shares":796,"price":133.0429,"value":105902.1484,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 796 shares of common stock issued upon vesting of 1,509 restricted stock units on February 13, 2024 to cover payroll and withholding taxes, with the balance of the shares (713) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $129.96 to $134.53. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"15,825 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":17976,"source":{"system":"sec-edgar","filing":"0000914475-24-000070","document":"wk-form4_1708036535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000070/wk-form4_1708036535.xml","form_type":"4"}},{"id":1654164,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-02-09T00:35:08.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":629,"price":136.78,"value":86034.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"15,825 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":17263,"source":{"system":"sec-edgar","filing":"0000914475-24-000050","document":"wk-form4_1707438893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000050/wk-form4_1707438893.xml","form_type":"4"}},{"id":1654163,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-02-09T00:35:08.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":700,"price":134.2298,"value":93960.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Sale of 700 shares of common stock issued upon vesting of 1,329 restricted stock units on February 8, 2024 to cover payroll and withholding taxes, with the balance of the shares (629) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2021. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $132.64 to $136.28 The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":17892,"source":{"system":"sec-edgar","filing":"0000914475-24-000050","document":"wk-form4_1707438893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000050/wk-form4_1707438893.xml","form_type":"4"}},{"id":1654162,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-02-09T00:35:08.000Z","date":"2024-02-06","kind":"sale","planned":true,"acquired":false,"shares":575,"price":141.96,"value":81627.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":17263,"source":{"system":"sec-edgar","filing":"0000914475-24-000050","document":"wk-form4_1707438893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000050/wk-form4_1707438893.xml","form_type":"4"}},{"id":1654161,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-02-09T00:35:08.000Z","date":"2024-02-06","kind":"sale","planned":true,"acquired":false,"shares":640,"price":142.1715,"value":90989.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 640 shares of common stock issued upon vesting of 1,215 restricted stock units on February 6, 2024 to cover payroll and withholding taxes, with the balance of the shares (575) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2021. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $141.05 to $143.13. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":17838,"source":{"system":"sec-edgar","filing":"0000914475-24-000050","document":"wk-form4_1707438893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000050/wk-form4_1707438893.xml","form_type":"4"}},{"id":1662745,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-02-03T00:11:58.000Z","date":"2024-01-31","kind":"sale","planned":true,"acquired":false,"shares":824,"price":141.94,"value":116958.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"15,825 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":17263,"source":{"system":"sec-edgar","filing":"0000914475-24-000025","document":"wk-form4_1706919106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000025/wk-form4_1706919106.xml","form_type":"4"}},{"id":1662744,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-02-03T00:11:58.000Z","date":"2024-01-31","kind":"sale","planned":true,"acquired":false,"shares":916,"price":140.7019,"value":128882.9404,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 916 shares of common stock issued upon vesting of 1,740 restricted stock units on January 31, 2024 to cover payroll and withholding taxes, with the balance of the shares (824) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 1, 2022. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $139.74 to $142.05. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":18087,"source":{"system":"sec-edgar","filing":"0000914475-24-000025","document":"wk-form4_1706919106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000025/wk-form4_1706919106.xml","form_type":"4"}},{"id":1699786,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2023-12-27T21:08:24.000Z","date":"2023-12-22","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":61.82,"value":618200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option granted October 02, 2017 of which 1/4th of the shares underlying the option becomes vested and exercisable on October 02, 2018 and an additional 1/48th of the shares underlying the option becomes vested and excercisable each month thereafter."}],"balance_after":23532,"derivative":{"exercise_price":61.82,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-059768","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123059768/doc4.xml","form_type":"4"}},{"id":1699785,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2023-12-27T21:08:24.000Z","date":"2023-12-22","kind":"exercise","planned":true,"acquired":false,"shares":14000,"price":81.05,"value":1134700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option granted February 07, 2019 and vested monthly over four years."}],"balance_after":8129,"derivative":{"exercise_price":81.05,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-23-059768","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123059768/doc4.xml","form_type":"4"}},{"id":1699784,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-12-27T21:08:24.000Z","date":"2023-12-22","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":126.7945,"value":1267945.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $125.00 to $128.00. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"15,825 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power."}],"balance_after":17263,"source":{"system":"sec-edgar","filing":"0001209191-23-059768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123059768/doc4.xml","form_type":"4"}},{"id":1699783,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-12-27T21:08:24.000Z","date":"2023-12-22","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":61.82,"value":618200.0,"ownership":{"direct":true},"balance_after":27263,"source":{"system":"sec-edgar","filing":"0001209191-23-059768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123059768/doc4.xml","form_type":"4"}},{"id":1699782,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-12-27T21:08:24.000Z","date":"2023-12-22","kind":"sale","planned":true,"acquired":false,"shares":14000,"price":129.9902,"value":1819862.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $129.95 to $130.15. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":17263,"source":{"system":"sec-edgar","filing":"0001209191-23-059768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123059768/doc4.xml","form_type":"4"}},{"id":1699781,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-12-27T21:08:24.000Z","date":"2023-12-22","kind":"exercise","planned":true,"acquired":true,"shares":14000,"price":81.05,"value":1134700.0,"ownership":{"direct":true},"balance_after":31263,"source":{"system":"sec-edgar","filing":"0001209191-23-059768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123059768/doc4.xml","form_type":"4"}},{"id":1787961,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-09-06T20:22:07.000Z","date":"2023-09-01","kind":"sale","planned":true,"acquired":false,"shares":824,"price":110.93,"value":91406.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":17263,"source":{"system":"sec-edgar","filing":"0001209191-23-048381","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123048381/doc4.xml","form_type":"4"}},{"id":1799011,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-08-24T00:03:21.000Z","date":"2023-08-21","kind":"sale","planned":true,"acquired":false,"shares":2132,"price":107.4065,"value":228990.658,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 2,132 shares of common stock issued upon vesting of 4,050 performance restricted stock units on August 21, 2023 to cover payroll and withholding taxes, with the balance of the shares (1,918) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person was previously granted performance restricted stock units that vest upon the achievement of certain milestones that occurred on August 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.05 to $108.42. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":18087,"source":{"system":"sec-edgar","filing":"0001209191-23-047133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123047133/doc4.xml","form_type":"4"}},{"id":1906917,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-05-03T21:28:47.000Z","date":"2023-05-01","kind":"sale","planned":true,"acquired":false,"shares":11397,"price":103.8913,"value":1184049.1461,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.82 to $104.12. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16169,"source":{"system":"sec-edgar","filing":"0001209191-23-027089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123027089/doc4.xml","form_type":"4"}},{"id":1912713,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-04-27T20:37:40.000Z","date":"2023-04-25","kind":"sale","planned":true,"acquired":false,"shares":100,"price":103.82,"value":10382.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 237 shares purchased on February 28, 2023 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan."}],"balance_after":27561,"source":{"system":"sec-edgar","filing":"0001209191-23-025862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123025862/doc4.xml","form_type":"4"}},{"id":2014203,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-16T00:08:55.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":6038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027."}],"balance_after":6038,"derivative":{"underlying":"Common Stock","underlying_shares":6038},"source":{"system":"sec-edgar","filing":"0001209191-23-009883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123009883/doc4.xml","form_type":"4"}},{"id":2014202,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Stock Option","published_at":"2023-02-16T00:08:55.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":37523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":37523,"derivative":{"exercise_price":103.52,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":37523},"source":{"system":"sec-edgar","filing":"0001209191-23-009883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123009883/doc4.xml","form_type":"4"}},{"id":2027018,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-02-09T00:56:31.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":628,"price":103.69,"value":65117.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":27424,"source":{"system":"sec-edgar","filing":"0001209191-23-007917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123007917/doc4.xml","form_type":"4"}},{"id":2027017,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-02-09T00:56:31.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":700,"price":103.9514,"value":72765.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Sale of 700 shares of common stock issued upon vesting of 1,328 restricted stock units on February 8, 2022 to cover payroll and withholding taxes, with the balance of the shares (628) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.58 to $105.72. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":28052,"source":{"system":"sec-edgar","filing":"0001209191-23-007917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123007917/doc4.xml","form_type":"4"}},{"id":2027016,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-02-09T00:56:31.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":822,"price":104.03,"value":85512.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":27424,"source":{"system":"sec-edgar","filing":"0001209191-23-007917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123007917/doc4.xml","form_type":"4"}},{"id":2027015,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-02-09T00:56:31.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":12801,"price":102.4073,"value":1310915.8473,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of 12,801 shares of common stock issued upon vesting of 24,298 performance restricted stock units on February 7, 2023 to cover payroll and withholding taxes, with the balance of the shares (11,497) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan"},{"field":"kind","element":"transactionCoding","label":"F7","text":"The Reporting Person was previously granted performance restricted stock units that vest upon the achievement of certain milestones that occurred on February 7, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.03 to $103.89. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":28246,"source":{"system":"sec-edgar","filing":"0001209191-23-007917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123007917/doc4.xml","form_type":"4"}},{"id":2027014,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-02-09T00:56:31.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":913,"price":102.2457,"value":93350.3241,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Sale of 913 shares of common stock issued upon vesting of 1,736 restricted stock units on February 7, 2023 to cover payroll and withholding taxes, with the balance of the shares (823) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.87 to $103.87. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16749,"source":{"system":"sec-edgar","filing":"0001209191-23-007917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123007917/doc4.xml","form_type":"4"}},{"id":2027013,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-02-09T00:56:31.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":575,"price":104.28,"value":59961.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":15926,"source":{"system":"sec-edgar","filing":"0001209191-23-007917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123007917/doc4.xml","form_type":"4"}},{"id":2027012,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-02-09T00:56:31.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":640,"price":105.4659,"value":67498.176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 640 shares of common stock issued upon vesting of 1,215 restricted stock units on February 6, 2022 to cover payroll and withholding taxes, with the balance of the shares (575) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.05 to $106.28. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16501,"source":{"system":"sec-edgar","filing":"0001209191-23-007917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123007917/doc4.xml","form_type":"4"}},{"id":2037152,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-02-02T22:07:54.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":916,"price":108.48,"value":99367.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 916 shares of common stock issued upon vesting of 1,740 restricted stock units on January 31, 2023 to cover payroll and withholding taxes, with the balance of the shares (824) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":15926,"source":{"system":"sec-edgar","filing":"0001209191-23-006267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123006267/doc4.xml","form_type":"4"}},{"id":2120408,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2022-11-10T22:47:15.000Z","date":"2022-11-08","kind":"exercise","acquired":false,"shares":5592,"price":81.05,"value":453231.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted February 07, 2019 and vested monthly over four years."}],"balance_after":22129,"derivative":{"exercise_price":81.05,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":5592},"source":{"system":"sec-edgar","filing":"0001209191-22-056435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122056435/doc4.xml","form_type":"4"}},{"id":2120407,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-11-10T22:47:15.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":5592,"price":124.9909,"value":698949.1128,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $124.95 to $125.09. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":15102,"source":{"system":"sec-edgar","filing":"0001209191-22-056435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122056435/doc4.xml","form_type":"4"}},{"id":2120406,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-11-10T22:47:15.000Z","date":"2022-11-08","kind":"exercise","acquired":true,"shares":5592,"price":81.05,"value":453231.6,"ownership":{"direct":true},"balance_after":20694,"source":{"system":"sec-edgar","filing":"0001209191-22-056435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122056435/doc4.xml","form_type":"4"}},{"id":2124805,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2022-11-04T21:02:02.000Z","date":"2022-11-03","kind":"exercise","acquired":false,"shares":7264,"price":81.05,"value":588747.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted February 07, 2019 and vested monthly over four years."}],"balance_after":27721,"derivative":{"exercise_price":81.05,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":7264},"source":{"system":"sec-edgar","filing":"0001209191-22-055819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122055819/doc4.xml","form_type":"4"}},{"id":2124804,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2022-11-04T21:02:02.000Z","date":"2022-11-02","kind":"exercise","acquired":false,"shares":1144,"price":81.05,"value":92721.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted February 07, 2019 and vested monthly over four years."}],"balance_after":34985,"derivative":{"exercise_price":81.05,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":1144},"source":{"system":"sec-edgar","filing":"0001209191-22-055819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122055819/doc4.xml","form_type":"4"}},{"id":2124803,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-11-04T21:02:02.000Z","date":"2022-11-03","kind":"sale","acquired":false,"shares":7264,"price":125.0047,"value":908034.1408,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $124.95 to $125.17. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":15102,"source":{"system":"sec-edgar","filing":"0001209191-22-055819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122055819/doc4.xml","form_type":"4"}},{"id":2124802,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-11-04T21:02:02.000Z","date":"2022-11-03","kind":"exercise","acquired":true,"shares":7264,"price":81.05,"value":588747.2,"ownership":{"direct":true},"balance_after":22366,"source":{"system":"sec-edgar","filing":"0001209191-22-055819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122055819/doc4.xml","form_type":"4"}},{"id":2124801,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-11-04T21:02:02.000Z","date":"2022-11-02","kind":"sale","acquired":false,"shares":1144,"price":124.9675,"value":142962.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $124.95 to $125.00. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":15102,"source":{"system":"sec-edgar","filing":"0001209191-22-055819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122055819/doc4.xml","form_type":"4"}},{"id":2124800,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-11-04T21:02:02.000Z","date":"2022-11-02","kind":"exercise","acquired":true,"shares":1144,"price":81.05,"value":92721.2,"ownership":{"direct":true},"balance_after":16246,"source":{"system":"sec-edgar","filing":"0001209191-22-055819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122055819/doc4.xml","form_type":"4"}},{"id":2191367,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-08-09T22:54:47.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":1816,"price":100,"value":181600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":15102,"source":{"system":"sec-edgar","filing":"0001209191-22-045082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122045082/doc4.xml","form_type":"4"}},{"id":2219606,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-06-29T20:26:44.000Z","date":"2022-06-27","kind":"sale","acquired":false,"shares":754,"price":100,"value":75400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 261 shares purchased on February 28, 2022 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan."}],"balance_after":16918,"source":{"system":"sec-edgar","filing":"0001209191-22-039808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122039808/doc4.xml","form_type":"4"}},{"id":2406966,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-02-09T23:55:50.000Z","date":"2022-02-08","kind":"sale","acquired":false,"shares":700,"price":79.5559,"value":55689.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Sale of 700 shares of common stock issued upon vesting of 1,328 restricted stock units on February 8, 2022 to cover payroll and withholding taxes, with the balance of the shares (628) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $79.10 to $79.96. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":17411,"source":{"system":"sec-edgar","filing":"0001209191-22-008205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122008205/doc4.xml","form_type":"4"}},{"id":2406965,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-02-09T23:55:50.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":640,"price":80.6253,"value":51600.192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Sale of 640 shares of common stock issued upon vesting of 1,215 restricted stock units on February 7, 2022 to cover payroll and withholding taxes, with the balance of the shares (575) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $79.76 to $81.14. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16783,"source":{"system":"sec-edgar","filing":"0001209191-22-008205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122008205/doc4.xml","form_type":"4"}},{"id":2406964,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-02-09T23:55:50.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":913,"price":80.7303,"value":73706.7639,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Sale of 913 shares of common stock issued upon vesting of 1,735 restricted stock units on February 7, 2022 to cover payroll and withholding taxes, with the balance of the shares (822) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $79.79 to $81.14. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16208,"source":{"system":"sec-edgar","filing":"0001209191-22-008205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122008205/doc4.xml","form_type":"4"}},{"id":2406963,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-02-09T23:55:50.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":605,"price":80.5475,"value":48731.2375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 605 shares of common stock issued upon vesting of 1,150 restricted stock units on February 7, 2022 to cover payroll and withholding taxes, with the balance of the shares (545) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $79.78 to $81.14. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":15386,"source":{"system":"sec-edgar","filing":"0001209191-22-008205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122008205/doc4.xml","form_type":"4"}},{"id":2417571,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-03T01:06:58.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":6961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of January 31, 2023, January 31, 2024, January 31, 2025, and January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of January 31, 2023, January 31, 2024, January 31, 2025, and January 31, 2026."}],"balance_after":6961,"derivative":{"underlying":"Common Stock","underlying_shares":6961},"source":{"system":"sec-edgar","filing":"0001209191-22-006592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122006592/doc4.xml","form_type":"4"}},{"id":2417570,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Stock Option","published_at":"2022-02-03T01:06:58.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":47401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on February 28, 2022 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":47401,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":47401},"source":{"system":"sec-edgar","filing":"0001209191-22-006592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122006592/doc4.xml","form_type":"4"}},{"id":2547544,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2021-10-06T20:37:38.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":987,"price":101.73,"value":100407.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 987 shares of common stock issued upon vesting of 1,875 restricted stock units on October 4, 2021 to cover payroll and withholding taxes, with the balance of the shares (888) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 216 shares acquired under the Neurocrine Biosciences 2018 Employee Stock Purchase Plan on February 26, 2021."}],"balance_after":14841,"source":{"system":"sec-edgar","filing":"0001209191-21-059839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919121059839/doc4.xml","form_type":"4"}},{"id":2769845,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Stock Option","published_at":"2021-03-29T10:13:38.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":35035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 8, 2021 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":35035,"derivative":{"exercise_price":117.63,"expiration_date":"2031-02-08","underlying":"Common Stock","underlying_shares":35035},"source":{"system":"sec-edgar","filing":"0001209191-21-023374","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919121023374/doc4a.xml","form_type":"4/A","original_submission_date":"2021-02-09"}},{"id":2872960,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41470,"kind":"person","name":"Cooke Julie","position":1,"cik":"0001776977","reported_name":"Cooke Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-10T02:24:47.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":5314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 8, 2022, February 8, 2023, February 8, 2024, and February 8, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 8, 2022, February 8, 2023, February 8, 2024, and February 8, 2025."}],"balance_after":5314,"derivative":{"underlying":"Common Stock","underlying_shares":5314},"source":{"system":"sec-edgar","filing":"0001209191-21-009125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919121009125/doc4.xml","form_type":"4"}}],"next_cursor":"2021-02-10T02:24:47.000000Z,2872960"}